Study Title: Peri-operative Immuno-Chemotherapy in Operable Oesophageal and Gastric Cancer
Conditions: Gastric Adenocarcinoma; Oesophageal Adenocarcinoma Intervention: Drug: FOLFOX-A Sponsors: Royal Marsden NHS Foundation Trust; Merck Serono International SA Recruiting
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου